{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:01:18Z","timestamp":1773302478908,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"experimental cancer medicines centre"},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["Grant OCay-04-169"],"award-info":[{"award-number":["Grant OCay-04-169"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"cancer research UK","doi-asserted-by":"publisher","award":["C1178\/A10294"],"award-info":[{"award-number":["C1178\/A10294"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"cancer research UK","doi-asserted-by":"publisher","award":["C7809\/A10342"],"award-info":[{"award-number":["C7809\/A10342"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["C7809\/A10342"],"award-info":[{"award-number":["C7809\/A10342"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRUK and EPSRC","award":["C1060\/A16464"],"award-info":[{"award-number":["C1060\/A16464"]}]},{"name":"CRUK and EPSRC","award":["C1060\/A10334"],"award-info":[{"award-number":["C1060\/A10334"]}]},{"name":"Sohn Foundation"},{"name":"Biomedical Research Centre at The Royal Marsden NHS Foundation Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11060-016-2151-8","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T12:09:27Z","timestamp":1463227767000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"129","author":[{"given":"Fernando","family":"Carceller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy A.","family":"Fowkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komel","family":"Khabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Saran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Burford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T. W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Hovestadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynley V.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucheta","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Mandeville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie R.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Laxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Al-Sarraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin O.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D. J.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios","family":"Zacharoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"2151_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453\u2013461","journal-title":"Lancet Oncol"},{"key":"2151_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","volume":"15","author":"N Verma","year":"2013","unstructured":"Verma N, Cowperthwaite MC, Burnett MG, Markey MK (2013) Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 15:515\u2013534","journal-title":"Neuro Oncol"},{"key":"2151_CR3","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"2151_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/ern.13.7","volume":"13","author":"TJ Kruser","year":"2013","unstructured":"Kruser TJ, Mehta MP, Robins HI (2013) Pseudoprogression after glioma therapy: a comprehensive review. Expert Rev Neurother 13:389\u2013403","journal-title":"Expert Rev Neurother"},{"key":"2151_CR5","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","volume":"26","author":"AA Brandes","year":"2008","unstructured":"Brandes AA, Franceschi E, Tosoni A et al (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192\u20132197","journal-title":"J Clin Oncol"},{"key":"2151_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-012-0872-x","volume":"109","author":"EM Thompson","year":"2012","unstructured":"Thompson EM, Guillaume DJ, D\u00f3sa E, Li X, Nazemi KJ, Gahramanov S, Hamilton BE, Neuwelt EA (2012) Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors. J Neurooncol 109:105\u2013114","journal-title":"J Neurooncol"},{"key":"2151_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/08880011003639978","volume":"27","author":"N Ozdemir","year":"2010","unstructured":"Ozdemir N, Celkan T (2010) Pseudoprogression after radiotherapy with concurrent temozolomide in a child with anaplastic astrocytoma. Pediatr Hematol Oncol 27:317\u2013319","journal-title":"Pediatr Hematol Oncol"},{"key":"2151_CR8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/neuonc\/nos212","volume":"14","author":"L Negretti","year":"2012","unstructured":"Negretti L, Blanchard P, Couanet D, Kieffer V, Goma G, Habrand JL, Dhermain F, Valteau-Couanet D, Grill J, Dufour C (2012) Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: impact on survival. Neuro Oncol 14:1413\u20131421","journal-title":"Neuro Oncol"},{"key":"2151_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106:399\u2013407","journal-title":"J Neurooncol"},{"key":"2151_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"2151_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205","journal-title":"Front Oncol"},{"key":"2151_CR12","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1158\/0008-5472.CAN-10-1250","volume":"70","author":"N Gaspar","year":"2010","unstructured":"Gaspar N, Marshall L, Perryman L et al (2010) MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX\/stem cell gene signature. Cancer Res 70:9243\u20139252","journal-title":"Cancer Res"},{"key":"2151_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-012-1040-z","volume":"112","author":"M Gessi","year":"2013","unstructured":"Gessi M, Gielen GH, Hammes J, D\u00f6rner E, Zur M\u00fchlen A, Waha A, Pietsch T (2013) H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? J Neurooncol 112:67\u201372","journal-title":"J Neurooncol"},{"key":"2151_CR14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00401-014-1337-4","volume":"128","author":"D Bechet","year":"2014","unstructured":"Bechet D, Gielen GGH, Korshunov A et al (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128:733\u2013741","journal-title":"Acta Neuropathol"},{"key":"2151_CR15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437","journal-title":"Cancer Cell"},{"key":"2151_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-012-1016-2","volume":"124","author":"P Bady","year":"2012","unstructured":"Bady P, Sciuscio D, Diserens A-C et al (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol 124:547\u2013560","journal-title":"Acta Neuropathol"},{"key":"2151_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S0317167100009628","volume":"37","author":"P Sanghera","year":"2010","unstructured":"Sanghera P, Perry J, Sahgal A, Symons S, Aviv R, Morrison M, Lam K, Davey P, Tsao MN (2010) Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci 37:36\u201342","journal-title":"Can J Neurol Sci"},{"key":"2151_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.WNL.0000133398.11870.9A","volume":"63","author":"MCY Wit de","year":"2004","unstructured":"de Wit MCY, de Bruin HG, Eijkenboom W, Sillevis Smitt PAE, van den Bent MJ (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63:535\u2013537","journal-title":"Neurology"},{"key":"2151_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cncr.23562","volume":"113","author":"W Taal","year":"2008","unstructured":"Taal W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Smitt PAES, van Es CA, van den Bent MJ (2008) Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 113:405\u2013410","journal-title":"Cancer"},{"key":"2151_CR20","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2008.20.7944","volume":"27","author":"JL Clarke","year":"2009","unstructured":"Clarke JL, Iwamoto FM, Sul J et al (2009) Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. J Clin Oncol 27:3861\u20133867","journal-title":"J Clin Oncol"},{"key":"2151_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S0317167100008131","volume":"36","author":"GB Rold\u00e1n","year":"2009","unstructured":"Rold\u00e1n GB, Scott JN, McIntyre JB et al (2009) Population-based study of pseudoprogression after chemoradiotherapy in GBM. Can J Neurol Sci 36:617\u2013622","journal-title":"Can J Neurol Sci"},{"key":"2151_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-009-9809-4","volume":"94","author":"ER Gerstner","year":"2009","unstructured":"Gerstner ER, McNamara MB, Norden AD, Lafrankie D, Wen PY (2009) Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression. J Neurooncol 94:97\u2013101","journal-title":"J Neurooncol"},{"key":"2151_CR23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3892\/ijo.2011.1260","volume":"40","author":"H-B Pouleau","year":"2012","unstructured":"Pouleau H-B, Sadeghi N, Bal\u00e9riaux D, M\u00e9lot C, De Witte O, Lefranc F (2012) High levels of cellular proliferation predict pseudoprogression in glioblastoma patients. Int J Oncol 40:923\u2013928","journal-title":"Int J Oncol"},{"key":"2151_CR24","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1200\/JCO.2011.40.9565","volume":"30","author":"M Stuplich","year":"2012","unstructured":"Stuplich M, Hadizadeh DR, Kuchelmeister K et al (2012) Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide. J Clin Oncol 30:e180\u2013e183","journal-title":"J Clin Oncol"},{"key":"2151_CR25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.surneu.2008.09.023","volume":"72","author":"C Chaskis","year":"2009","unstructured":"Chaskis C, Neyns B, Michotte A, De Ridder M, Everaert H (2009) Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol 72:423\u2013428","journal-title":"Surg Neurol"},{"key":"2151_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/neuonc\/nou129","volume":"17","author":"A Radbruch","year":"2015","unstructured":"Radbruch A, Fladt J, Kickingereder P et al (2015) Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence. Neuro Oncol 17:151\u2013159","journal-title":"Neuro Oncol"},{"key":"2151_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/102490791101800406","volume":"18","author":"DTM Chan","year":"2012","unstructured":"Chan DTM, Ng RYT, Siu DYW et al (2012) Pseudoprogression of malignant glioma in Chinese patients receiving concomitant chemoradiotherapy. Hong Kong Med J 18:221\u2013225","journal-title":"Hong Kong Med J"},{"key":"2151_CR28","doi-asserted-by":"crossref","first-page":"690585","DOI":"10.1155\/2013\/690585","volume":"2013","author":"P Linhares","year":"2013","unstructured":"Linhares P, Carvalho B, Figueiredo R, Reis RM, Vaz R (2013) Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: the Value of RANO Evaluation. J Oncol 2013:690585","journal-title":"J Oncol"},{"key":"2151_CR29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3340\/jkns.2014.55.1.5","volume":"55","author":"JH Chang","year":"2014","unstructured":"Chang JH, Kim C-Y, Choi BS, Kim YJ, Kim JS, Kim IA (2014) Pseudoprogression and pseudoresponse in the management of high-grade glioma: optimal decision timing according to the response assessment of the neuro-oncology working group. J Korean Neurosurg Soc 55:5\u201311","journal-title":"J Korean Neurosurg Soc"},{"key":"2151_CR30","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3174\/ajnr.A2397","volume":"32","author":"LC Hygino da Cruz","year":"2011","unstructured":"Hygino da Cruz LC, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 32:1978\u20131985","journal-title":"AJNR Am J Neuroradiol"},{"key":"2151_CR31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/pbc.24562","volume":"60","author":"KE Warren","year":"2013","unstructured":"Warren KE, Poussaint TY, Vezina G et al (2013) Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer 60:1397\u20131401","journal-title":"Pediatr Blood Cancer"},{"key":"2151_CR32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1754-9485.2011.02319.x","volume":"55","author":"A Gunjur","year":"2011","unstructured":"Gunjur A, Lau E, Taouk Y, Ryan G (2011) Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis. J Med Imaging Radiat Oncol 55:603\u2013610","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2151_CR33","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.0b013e31821d74e7","volume":"76","author":"RJ Young","year":"2011","unstructured":"Young RJ, Gupta A, Shah AD, Graber JJ, Zhang Z, Shi W, Holodny AI, Omuro AMP (2011) Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology 76:1918\u20131924","journal-title":"Neurology"},{"key":"2151_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","volume":"82","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82:81\u201383","journal-title":"J Neurooncol"},{"key":"2151_CR35","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2009.25.3971","volume":"28","author":"C Tsien","year":"2010","unstructured":"Tsien C, Galb\u00e1n CJ, Chenevert TL et al (2010) Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol 28:2293\u20132299","journal-title":"J Clin Oncol"},{"key":"2151_CR36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.clineuro.2010.05.003","volume":"112","author":"E Yaman","year":"2010","unstructured":"Yaman E, Buyukberber S, Benekli M, Oner Y, Coskun U, Akmansu M, Ozturk B, Kaya AO, Uncu D, Yildiz R (2010) Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide. Clin Neurol Neurosurg 112:662\u2013667","journal-title":"Clin Neurol Neurosurg"},{"key":"2151_CR37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2008.11.003","volume":"111","author":"C Peca","year":"2009","unstructured":"Peca C, Pacelli R, Elefante A, De Caro MD, Vergara P, Mariniello G, Giamundo A, Maiuri F (2009) Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? Clin Neurol Neurosurg 111:331\u2013334","journal-title":"Clin Neurol Neurosurg"},{"key":"2151_CR38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/COC.0b013e318210f54a","volume":"35","author":"E Topkan","year":"2012","unstructured":"Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B (2012) Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Am J Clin Oncol 35:284\u2013289","journal-title":"Am J Clin Oncol"},{"key":"2151_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-010-0305-7","volume":"102","author":"H-C Kang","year":"2011","unstructured":"Kang H-C, Kim C-Y, Han JH, Choe GY, Kim JH, Kim JH, Kim IA (2011) Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53. J Neurooncol 102:157\u2013162","journal-title":"J Neurooncol"},{"key":"2151_CR40","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3174\/ajnr.A4428","volume":"36","author":"R Ceschin","year":"2015","unstructured":"Ceschin R, Kurland BF, Abberbock SR, Ellingson BM, Okada H, Jakacki RI, Pollack IF, Panigrahy A (2015) Parametric response mapping of apparent diffusion coefficient as an imaging biomarker to distinguish pseudoprogression from true tumor progression in peptide-based vaccine therapy for pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 36:2170\u20132176","journal-title":"AJNR Am J Neuroradiol"},{"key":"2151_CR41","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/neuonc\/not328","volume":"16","author":"M Nasseri","year":"2014","unstructured":"Nasseri M, Gahramanov S, Netto JP, Fu R, Muldoon LL, Varallyay C, Hamilton BE, Neuwelt EA (2014) Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question. Neuro Oncol 16:1146\u20131154","journal-title":"Neuro Oncol"},{"key":"2151_CR42","first-page":"2607","volume":"29","author":"A Fabi","year":"2009","unstructured":"Fabi A, Russillo M, Metro G, Vidiri A, Di Giovanni S, Cognetti F (2009) Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice. Anticancer Res 29:2607\u20132610","journal-title":"Anticancer Res"},{"key":"2151_CR43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3174\/ajnr.A2286","volume":"32","author":"D-S Kong","year":"2011","unstructured":"Kong D-S, Kim ST, Kim E-H, Lim DH, Kim WS, Suh Y-L, Lee J-I, Park K, Kim JH, Nam D-H (2011) Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status. AJNR Am J Neuroradiol 32:382\u2013387","journal-title":"AJNR Am J Neuroradiol"},{"key":"2151_CR44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/neuonc\/noq162","volume":"13","author":"C-K Park","year":"2011","unstructured":"Park C-K, Kim J, Yim SY et al (2011) Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients. Neuro Oncol 13:195\u2013202","journal-title":"Neuro Oncol"},{"key":"2151_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253","journal-title":"Nat Genet"},{"key":"2151_CR46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","volume":"129","author":"A Korshunov","year":"2015","unstructured":"Korshunov A, Ryzhova M, Hovestadt V et al (2015) Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 129:669\u2013678","journal-title":"Acta Neuropathol"},{"key":"2151_CR47","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3174\/ajnr.A4218","volume":"36","author":"AJ Prager","year":"2015","unstructured":"Prager AJ, Martinez N, Beal K, Omuro A, Zhang Z, Young RJ (2015) Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol 36:877\u2013885","journal-title":"AJNR Am J Neuroradiol"},{"key":"2151_CR48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00234-009-0613-9","volume":"52","author":"E Matsusue","year":"2010","unstructured":"Matsusue E, Fink JR, Rockhill JK, Ogawa T, Maravilla KR (2010) Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 52:297\u2013306","journal-title":"Neuroradiology"},{"key":"2151_CR49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clinimag.2012.08.008","volume":"37","author":"V Hatzoglou","year":"2013","unstructured":"Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ (2013) Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients. Clin Imaging 37:451\u2013457","journal-title":"Clin Imaging"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2151-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2151-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T13:42:19Z","timestamp":1567863739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2151-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2151-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}